APEIRON Announces Collaboration with Lead Discovery Center GmbH

Alliance for medicinal chemistry optimization and development of novel checkpoint blockade approach.

Press release

Presseaussendung

Copyright © 2020 APEIRON Biologics AG. All rights reserved.